首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease
【2h】

Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease

机译:Sirtuin 1表达的微调对于保护肝脏免受胆​​汁淤积性肝病至关重要

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Cholestasis comprises aetiologically heterogeneous conditions characterized by accumulation of bile acids in the liver that actively contribute to liver damage. Sirtuin 1 (SIRT1) regulates liver regeneration and bile acid metabolism by modulating farnesoid X receptor (FXR); we here investigate its role in cholestatic liver disease. We determined SIRT1 expression in livers from patients with cholestatic disease, in two experimental models of cholestasis, as well as in human and murine liver cells in response to bile acid loading. SIRT1‐overexpressing (SIRToe) and hepatocyte‐specific SIRT1‐KO (knockout) mice (SIRThep–/–) were subjected to bile duct ligation (BDL) and were fed with a 0.1% DDC (3,5‐diethoxycarbonyl‐1,4‐dihydrocollidine) diet to determine the biological relevance of SIRT1 during cholestasis. The effect of NorUDCA (24‐norursodeoxycholic acid) was tested in BDL/SIRToe mice. We found that SIRT1 was highly expressed in livers from cholestatic patients, mice after BDL, and Mdr2 knockout mice (Mdr2–/–) animals. The detrimental effects of SIRT1 during cholestasis were validated in vivo and in vitro. SIRToe mice showed exacerbated parenchymal injury whereas SIRThep–/– mice evidenced a moderate improvement after BDL and 0.1% DDC feeding. Likewise, hepatocytes isolated from SIRToe mice showed increased apoptosis in response to bile acids, whereas a significant reduction was observed in SIRThep–/– hepatocytes. Importantly, the decrease, but not complete inhibition, of SIRT1 exerted by norUDCA treatment correlated with pronounced improvement in liver parenchyma in BDL/SIRToe mice. Interestingly, both SIRT1 overexpression and hepatocyte‐specific SIRT1 depletion correlated with inhibition of FXR, whereas modulation of SIRT1 by NorUDCA associated with restored FXR signaling. Conclusion: SIRT1 expression is increased during human and murine cholestasis. Fine‐tuning expression of SIRT1 is essential to protect the liver from cholestatic liver damage.
机译:胆汁淤积包括病因学上的异质性疾病,其特征在于胆汁酸在肝脏中的积聚,从而积极地促进了肝的损害。 Sirtuin 1(SIRT1)通过调节法呢素X受体(FXR)调节肝脏再生和胆汁酸代谢;我们在这里研究其在胆汁淤积性肝病中的作用。我们确定了胆汁淤积性疾病患者的肝中,两种胆汁淤积的实验模型以及响应胆汁酸负荷的人和鼠肝细胞中SIRT1的表达。将SIRT1过表达(SIRT oe )和肝细胞特异性SIRT1-KO(敲除)小鼠(SIRT hep – / – )进行胆管结扎(BDL),喂食0.1%DDC(3,5-二乙氧基羰基-1,4-二氢可力丁)饮食以确定胆汁淤积期间SIRT1的生物学相关性。在BDL / SIRT oe 小鼠中测试了NorUDCA(24-去甲去氧胆酸)的作用。我们发现,SIRT1在胆汁淤积患者,BDL后小鼠和Mdr2基因敲除小鼠(Mdr2 – / – )动物的肝脏中高表达。在体内和体外验证了胆汁淤积中SIRT1的有害作用。 SIRT oe 小鼠表现出严重的实质损伤,而SIRT hep – / – 小鼠在BDL和0.1%DDC喂养后表现出中等程度的改善。同样,从SIRT oe 小鼠中分离出的肝细胞显示出对胆汁酸反应的凋亡增加,而在SIRT hep – / – 肝细胞中观察到了显着的减少。重要的是,norUDCA处理对SIRT1的减少(但不是完全抑制)与BDL / SIRT oe 小鼠肝实质的明显改善有关。有趣的是,SIRT1过表达和肝细胞特异性SIRT1耗竭均与FXR抑制相关,而NorUDCA对SIRT1的调节与恢复的FXR信号相关。结论:SIRT1在人和鼠胆汁淤积过程中表达增加。 SIRT1的微调表达对于保护肝脏免受胆​​汁淤积性肝损害至关重要。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号